chr10-96157407-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001330736.2(ZNF518A):c.1085G>A(p.Ser362Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,612,928 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001330736.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZNF518A | NM_001330736.2 | c.1085G>A | p.Ser362Asn | missense_variant | 6/6 | ENST00000316045.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZNF518A | ENST00000316045.10 | c.1085G>A | p.Ser362Asn | missense_variant | 6/6 | 1 | NM_001330736.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152098Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000650 AC: 16AN: 246218Hom.: 0 AF XY: 0.0000823 AC XY: 11AN XY: 133656
GnomAD4 exome AF: 0.0000459 AC: 67AN: 1460712Hom.: 0 Cov.: 32 AF XY: 0.0000702 AC XY: 51AN XY: 726576
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.000107 AC XY: 8AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.1085G>A (p.S362N) alteration is located in exon 6 (coding exon 1) of the ZNF518A gene. This alteration results from a G to A substitution at nucleotide position 1085, causing the serine (S) at amino acid position 362 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at